BLB's H1 net profit surges

On 25 Aug., Baolingbao Biology Co., Ltd. (BLB) issued its financial report for H1 2022. Lower procurement costs of raw and auxiliary materials and efforts to reduce costs in R&D and management led to a surge in net profit. As the company has stocked ...

Sweeteners China News 202208

www.cnchemicals.com